Ten-year outcome of Eculizumab in kidney transplant recipients with atypical hemolytic uremic syndrome– a single center experience

Overview of attention for article published in BMC Nephrology, May 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

So far, Altmetric has seen 22 X posts from 19 X users, with an upper bound of 33,798 followers.

RT @hopkinsneph: Study from @kantsmd @nadaalachkar @samialasfar- 'Ten-year outcome of Eculizumab in kidney transplant recipients with atypi…

RT @hopkinsneph: Study from @kantsmd @nadaalachkar @samialasfar- 'Ten-year outcome of Eculizumab in kidney transplant recipients with atypi…

RT @hopkinsneph: Study from @kantsmd @nadaalachkar @samialasfar- 'Ten-year outcome of Eculizumab in kidney transplant recipients with atypi…

RT @hopkinsneph: Study from @kantsmd @nadaalachkar @samialasfar- 'Ten-year outcome of Eculizumab in kidney transplant recipients with atypi…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 18 additional X posts.